Table 1.
Demographic data and clinical characteristics of COVID-19 patients and control group.
| Characteristic | All COVID-19 patients | Days between symptom onset and sample collection |
Control group |
||
|---|---|---|---|---|---|
| ≤7 days | 8–14 days | >14 days | |||
| N | 101 | 28 (27.7%) | 40 (39.6%) | 33 (32.7%) | 70 |
| Age median (IQR) | 48.0 (40.0–57.0) |
50.0 (39.3–56.8) | 49.0 (41.3–58.5) | 46.0 (34.3–55.5) | 36.0 (30.3–45.0) |
| Gender | |||||
| Male | 76 (89.1%) | 25 (89.3%) | 40 (100%) | 11 (33.3%) | 58 (82.9%) |
| Female | 4 (4.9%) | 3 (10.7%) | – | 1 (3.0%) | 6 (8.6%) |
| N/A | 21 (20.8%) | – | – | 21 (63.6%) | 6 (8.6%) |
| Sample source | |||||
| Hospitalized, non-ICU patients | 45 (44.6%) | 17 (60.7%) | 23 (57.5%) | 5 (15.2%) | – |
| ICU-admitted patients | 35 (34.7%) | 11 (39.3%) | 17 (42.5%) | 7 (21.2%) | – |
| Recovered convalescent plasma donors | 21 (20.8%) | – | – | 21 (63.6%) | – |